Analyst Reco. COMPASS Pathways plc

Equities

CMPS

US20451W1018

Real-time Estimate Cboe BZX Other stock markets 15:36:38 03/05/2024 BST			5-day change	1st Jan Change
8.755 ^USD	+6.12%		+12.59%	+2.17%

04-29	Compass Pathways and Journey Clinical Establish Research Collaboration Agreement to Inform the Training of Healthcare Providers and Delivery Model for Comp360 Psilocybin Treatment, If Approved for Treatment-Resistant Depression	CI
04-18	Compass Pathways Insider Sold Shares Worth $597,964, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Compass Pathways Insider Sold Shares Worth $597,964, According to a Recent SEC Filing	04-18	MT
Compass Pathways Insider Sold Shares Worth $597,964, According to a Recent SEC Filing	04-18	MT
Compass Pathways Insider Sold Shares Worth $461,332, According to a Recent SEC Filing	04-02	MT
Compass Pathways Insider Sold Shares Worth $461,332, According to a Recent SEC Filing	04-02	MT
Compass Pathways Insider Sold Shares Worth $445,552, According to a Recent SEC Filing	04-01	MT
Compass Pathways Insider Sold Shares Worth $445,552, According to a Recent SEC Filing	04-01	MT
Morgan Stanley Initiates COMPASS Pathways at Overweight With $30 Price Target	04-01	MT
Deutsche Bank Initiates Coverage on COMPASS Pathways With Buy Rating, $16 Price Target	12-12	MT
Canaccord Genuity Cuts Price Target on COMPASS Pathways to $50 From $60, Maintains Buy Rating	22/08/23	MT
Citigroup Adjusts Price Target on COMPASS Pathways to $19 From $45, Maintains Buy Rating	01/03/23	MT
EF Hutton Initiates COMPASS Pathways at Buy With $38 Price Target	16/12/22	MT
Oppenheimer Adjusts COMPASS Pathways Price Target to $33 From $55, Maintains Outperform Rating	09/12/22	MT
Berenberg Resumes COMPASS Pathways at Buy With $33 Price Target	21/11/22	MT
Loop Capital Initiates COMPASS Pathways at Buy With $34 Price Target	01/11/22	MT
Oppenheimer Adjusts COMPASS Pathways Price Target to $55 From $65, Maintains Outperform Rating	13/10/22	MT
Citigroup Trims Price Target on COMPASS Pathways to $46 From $49, Reiterates Buy Rating	05/08/22	MT
Berenberg Bank Suspends Coverage of 25 Companies in Consumer Discretionary, Healthcare, Industrial Tech, and Software Sectors	01/07/22	MT
Berenberg European Conference	05/12/21	FA
HC Wainwright Adjusts COMPASS Pathways' Price Target to $120 from $100, Keeps Buy Rating	22/11/21	MT
Berenberg Bank Adjusts COMPASS Pathways PT to $84 From $50, Maintains Buy Rating	16/11/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. COMPASS Pathways plc

Equities

CMPS

US20451W1018

Analyst Reco.

Filters